Lenvaxen 4 mg is a tyrosine kinase inhibitor used in thyroid, liver, and kidney cancers. It blocks multiple pathways that support tumor growth and blood vessel formation. Lenvaxen helps slow disease progression and is often part of advanced cancer treatment regimens.